Patents by Inventor Sandra Wainer

Sandra Wainer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Adeno-associated vectors for enhanced transduction and reduced immunogenicity
    Patent number: 10081659
    Abstract: A modified adeno-associated virus (AAV) capsid protein comprising at least one non-native amino acid that confers to the modified AAV particles new properties, such as increased transduction efficiency and reduced immunogenicity. These modified AAV proteins and particles are particularly useful for gene therapy and the treatment of various diseases and conditions.
    Type: Grant
    Filed: April 6, 2016
    Date of Patent: September 25, 2018
    Assignees: The United States of America, as represented by the Secretary, Dept. of Health and Human Services, University of Florida Research Foundation, Inc.
    Inventors: John A. Chiorini, Sandra Wainer, Mavis Agbandje-McKenna, Sujata Halder
  • Adeno-Associated Vectors for Enhanced Transduction and Reduced Immunogenicity
    Publication number: 20160289275
    Abstract: A modified adeno-associated virus (AAV) capsid protein comprising at least one non-native amino acid that confers to the modified AAV particles new properties, such as increased transduction efficiency and reduced immunogenicity. These modified AAV proteins and particles are particularly useful for gene therapy and the treatment of various diseases and conditions.
    Type: Application
    Filed: April 6, 2016
    Publication date: October 6, 2016
    Inventors: John A. Chiorini, Sandra Wainer, Mavis Agbandje-McKenna, Sujata Halder